2m 2m 2m 2m 2m 2m 2m
IBIO (IBIO)
NASDAQ
$1.10-$0.01 (-0.90%)
Price as of Oct 02, 2026 7:06 PM EDT- $71.4MMarket Cap
- 33.11%1-Year Change
- BiotechnologyIndustry
IBIO (IBIO)
$1.10-$0.01 (-0.90%)
Annual
Quarterly
06/30/2026 | 06/30/2025 | 06/30/2024 | 06/30/2023 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 100,000 -75.00% | 400,000 +77.78% | 225,000 N/A | 0 -100.00% | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 100,000 -75.00% | 400,000 +77.78% | 225,000 N/A | 0 -100.00% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -19.6M +136.32% | -8.3M +60.31% | -5.2M -49.79% | -10.3M -41.75% | |
Depreciation and Amortization Expense | 20,000 0.00% | 20,000 0.00% | 20,000 -84.13% | 126,000 -68.58% | |
Total Operating Expenses | 35.2M +85.46% | 19.0M +12.71% | 16.9M -42.55% | 29.3M -43.42% | |
Operating Profit | -35.1M +88.91% | -18.6M +11.83% | -16.6M -43.31% | -29.3M -40.95% | |
Interest Income | 2.1M +391.99% | 437,000 +20.39% | 363,000 +70.42% | 213,000 +19.66% | |
Interest Expense | -1,000 -94.12% | -17,000 -51.43% | -35,000 -57.83% | -83,000 -94.12% | |
Interest Income and Expense and Net | 2.1M +411.67% | 420,000 +28.05% | 328,000 +152.31% | 130,000 +110.53% | |
Total Nonoperating Income and Expense | 2.1M +832.00% | 225,000 -81.11% | 1.2M +3,621.88% | 32,000 +105.21% | |
Income before Taxes | -33.0M +79.81% | -18.4M +19.00% | -15.4M -47.31% | -29.3M -41.83% | |
Income Taxes | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Extraordinary Items | N/A N/A | 3.1M N/A | N/A N/A | N/A N/A | |
Net Income | -33.0M +79.81% | -18.4M -26.22% | -24.9M -61.69% | -65.0M +29.24% | |
Net Income from Continuing Operations Applicable to Common | -33.0M +79.81% | -18.4M +19.00% | -15.4M -47.31% | -29.3M -41.83% | |
Basic EPS and Net Income | -0.32 -81.71% | -1.75 -73.08% | -6.50 +22.41% | -5.31 -8.13% | |
Diluted EPS and Net Income | -0.32 -81.71% | -1.75 -73.08% | -6.50 +22.41% | -5.31 -8.13% | |
Basic Weighted Average Shares | 104.1M +891.14% | 10.5M +174.05% | 3.8M -68.71% | 12.2M +40.41% | |
Diluted Weighted Average Shares | 104.1M +891.14% | 10.5M +174.05% | 3.8M -68.71% | 12.2M +40.41% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 56.4M +557.13% | 8.6M -39.61% | 14.2M +230.39% | 4.3M -81.03% | |
Short-Term Investments | 31.6M N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 88.0M +925.86% | 8.6M -39.61% | 14.2M +230.39% | 4.3M -81.03% | |
Total Current Assets | 92.2M +848.68% | 9.7M -37.97% | 15.7M -40.32% | 26.3M -41.74% | |
Accumulated Depreciation | 2.1M +37.32% | 1.5M +47.87% | 1.0M +152.75% | 400,000 -88.57% | |
Property and Plant and Equipment and Net | 3.1M -2.43% | 3.2M -12.91% | 3.6M -13.91% | 4.2M -88.49% | |
Total Long-Term Assets | 3.1M -2.43% | 3.2M -12.91% | 3.6M -13.91% | 4.2M -88.49% | |
Total Assets | 99.1M +327.47% | 23.2M -19.31% | 28.7M -30.27% | 41.2M -58.55% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | 830,000 0.00% | 830,000 -93.77% | 13.3M +3.06% | 12.9M -41.62% | |
Total Current Liabilities | 11.7M +92.35% | 6.1M +59.01% | 3.8M -82.21% | 21.6M -29.09% | |
Total Long-Term Debt | 0 -100.00% | 829,000 0.00% | 829,000 -93.77% | 13.3M +2,116.67% | |
Total Long-Term Liabilities | 1.7M -44.28% | 3.0M -14.16% | 3.5M +10.53% | 3.1M -48.39% | |
Total Liabilities | 13.4M +61.31% | 8.3M +12.08% | 7.4M -71.31% | 25.8M -28.10% | |
Retained Earnings | -365.3M +9.95% | -332.2M +5.86% | -313.8M +8.62% | -288.9M +29.03% | |
Total Stockholders Equity | 85.7M +476.03% | 14.9M -30.22% | 21.3M +38.64% | 15.4M -75.77% | |
Total Shares Outstanding | 55.7M +187.86% | 19.3M +124.37% | 8.6M -57.54% | 20.3M +132.72% | |
Cash Flow | |||||
Cash from Operating Activities | -23.2M +51.71% | -15.3M -17.52% | -18.6M -39.04% | -30.4M -18.79% | |
Capital Expenditures | 578,000 +3,512.50% | 16,000 -92.38% | 210,000 -96.34% | 5.7M -21.72% | |
Cash from Investing Activities | -32.0M -4,412.53% | 742,000 -18.10% | 906,000 -87.07% | 7.0M +236.71% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 103.0M +1,054.08% | 8.9M -63.55% | 24.5M +964.49% | 2.3M +137.57% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | -35,141.00% +655.64% | -4,650.50% -37.09% | -7,392.89% N/A | N/A N/A | |
Return on Assets | -54.04% -23.66% | -70.79% -0.61% | -71.22% -22.97% | -92.47% +126.44% | |
Return on Equity | -65.70% -35.28% | -101.52% -25.20% | -135.71% -17.68% | -164.86% +181.97% | |
Revenue Growth | -75.00% -196.43% | 77.78% N/A | N/A N/A | -100.00% -19,858.94% | |
Current Ratio | 7.85 +393.21% | 1.59 -60.99% | 4.08 +235.43% | 1.22 -17.83% | |
Cash Ratio | 4.80 +241.63% | 1.41 -62.02% | 3.70 +1,756.75% | 0.20 -73.25% | |
Debt-to-Equity Ratio | 0.010 -91.30% | 0.11 -83.21% | 0.66 -61.07% | 1.71 +375.82% | |
Debt-to-Assets Ratio | 0.008 -88.27% | 0.07 -85.47% | 0.49 -22.59% | 0.64 +178.03% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow